Form 4: Dexcom Executive Sadie Stern Sells Shares to Cover Tax Obligations

Dexcom's EVP, Chief HR Officer, Sadie Stern, sold 4,259 shares of common stock to cover tax obligations related to vesting restricted stock units.

Summary

• Sadie Stern, EVP and Chief HR Officer at Dexcom Inc., sold 4,259 shares of common stock on November 20, 2024, at a price of $74.73 per share.
• This sale was not a discretionary trade but was mandated by Dexcom's equity incentive plan to cover tax withholding obligations associated with the vesting of restricted stock units (RSUs).
• Following the transaction, Stern beneficially owns 71,192 shares of Dexcom common stock, which includes 44,115 unvested restricted stock units.
• These unvested RSUs were granted on various dates and will vest through March 8, 2027, December 15, 2024, March 8, 2026 and March 8, 2025.

Sentiment

Score: 5

Explanation: The document reflects a routine transaction related to executive compensation and does not indicate any positive or negative sentiment about the company's performance.

Industry Context

This is a routine transaction related to executive compensation and is common practice for companies with equity-based compensation plans. It does not indicate any change in the company's performance or outlook.

Comparison to Industry Standards

• Executive stock sales to cover tax obligations are a standard practice across publicly traded companies, particularly those that offer equity compensation.
• The vesting schedules for the restricted stock units are typical for executive compensation packages, with vesting periods of three to four years.

Stakeholder Impact

• The sale of shares by an executive may have a minor impact on the stock price, but this is a routine transaction and not expected to have a significant impact.

Key Dates

Keywords

Dexcom, insider trading, stock sale, executive, restricted stock units, tax obligations, equity compensation